Dexmedetomidine-induced polysomnography as a diagnostic method in obstructive sleep apnea: a reliable alternative method?

Yan Wu,Renqiang Ma,Qian Zhou,Ho Yin Lau,Yongquan Wang,Jian Li,Weiping Wen
DOI: https://doi.org/10.1016/j.sleep.2021.01.005
IF: 4.842
2021-03-01
Sleep Medicine
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Under-diagnosis of obstructive sleep apnea (OSA) is common because of the demanding and time-consuming nature of polysomnography (PSG). Herein, we assessed the utility of a short daytime dexmedetomidine-induced PSG for diagnosis of OSA in adults.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>This was a single-center, prospective, diagnostic trial. We evaluated 86 patients using a full overnight PSG and a short diurnal drug-induced PSG (DIPSG). DIPSG was induced by continuous intravenous dexmedetomidine infusion. Sedation depth was monitored and maintained using the Narcotrend index (50−70). Diagnostic performance for DIPSG with different apnea-hypopnea index (AHI) cut-off values were calculated. Bland−Altman plots used for analysis. Sleep architecture and position were compared.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We studied 47 OSA patients and 39 healthy volunteers. Sensitivity and specificity for detection of OSA by DIPSG were 92% and 79%, respectively, for an AHI cut-off value of 5, 90% and 77%, respectively, for an AHI cut-off value of 15, and 95% and 85%, respectively, for an AHI cut-off value of 30. The DIPSG bias was −5 (−25; 15) for AHI and −3 (−13; 7) for minimal oxygen saturation. N2 sleep was increased (32.9% vs. 50.75%, respectively; <em>p</em> &lt; 0.01) and REM sleep was decreased (21.35% vs. 1.24%, respectively; <em>p</em> &lt; 0.01) during DIPSG. Twenty-eight (33%) participants had postural shifts during DIPSG. No significant adverse events were observed during DIPSG.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Dexmedetomidine-induced PSG had a good sensitivity and specificity, and can be used as a screening tool for diagnosis of OSA in adults.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Chinese Clinical Trial Registration</h3><p>ChiCTR1900024044.</p>
clinical neurology
What problem does this paper attempt to address?